JOURNAL ARTICLE

Cytarabine/daunorubicin/etoposide

Year: 2013 Journal:   Reactions Weekly Vol: 1441 (1)Pages: 13-13   Publisher: Adis, Springer Healthcare
Keywords:
Daunorubicin Etoposide Cytarabine Medicine Pharmacology Internal medicine Leukemia Chemotherapy

Metrics

0
Cited By
0.00
FWCI (Field Weighted Citation Impact)
1
Refs
0.46
Citation Normalized Percentile
Is in top 1%
Is in top 10%

Topics

Methemoglobinemia and Tumor Lysis Syndrome
Health Sciences →  Medicine →  Pulmonary and Respiratory Medicine
Neutropenia and Cancer Infections
Health Sciences →  Medicine →  Oncology
Chemotherapy-related skin toxicity
Health Sciences →  Medicine →  Dermatology

Related Documents

JOURNAL ARTICLE

Cytarabine/cytarabine/daunorubicin/etoposide

Journal:   Reactions Weekly Year: 2022 Vol: 1917 (1)Pages: 201-201
JOURNAL ARTICLE

Cytarabine/daunorubicin/etoposide

Journal:   Reactions Weekly Year: 2013 Vol: 1439 (1)Pages: 13-13
JOURNAL ARTICLE

Cytarabine/daunorubicin/etoposide

Journal:   Reactions Weekly Year: 2015 Vol: 1574 (1)Pages: 88-88
JOURNAL ARTICLE

Cytarabine/daunorubicin/etoposide

Journal:   Reactions Weekly Year: 2016 Vol: 1583 (1)Pages: 365-365
JOURNAL ARTICLE

Cytarabine/daunorubicin/etoposide

Journal:   Reactions Weekly Year: 2018 Vol: 1709 (1)Pages: 72-72
© 2026 ScienceGate Book Chapters — All rights reserved.